TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER i: MATERNAL AND CHILD HEALTH
PART 665 CHILD HEALTH EXAMINATION CODE
SECTION 665.APPENDIX B VACCINATION SCHEDULE FOR HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINES (HIB)


 

Section 665.APPENDIX B  Vaccination Schedule for Haemophilus influenzae type b Conjugate Vaccines (Hib)

 

Vaccination Schedule for Haemophilus influenzae type b Conjugate Vaccines (Hib)

Note:  Vaccines are interchangeable.  Any combination of 3 doses of conjugate vaccine constitutes a primary series.  Similarly, a DTP/Hib combination vaccine can be used in place of HbOC or PRP-T.

 

Vaccine

Age at 1st Dose (months)

Primary Series

Booster

Total Number of Doses

HbOC

HibTITER ®

Wyeth/Lederle

or

DTP/HbOC

TETRAMUNE ®

Wyeth/Lederle

or

PRP-T

ActHIB ®

Aventis Pasteur

OmniHib ®

GlaxoSmithKline

2-6

3 doses, 2 months apartj

12-15 months

4

7-11

2 doses, 2 months

apartj

12-18 months

k, l

3

12-14

1 dose

2 months later l

2

15-59

1 dose m

None

1

PRP-OMP

 

PedvaxHIB ®

Merck

COMVAX ®

Merck

2-6

2 doses,

2 months apartj

12-15 months k,

l

3

7-11

2 doses, 2 months

apartj

12-18

months k, l

3

12-14

1 dose

2 months later l

2

15-59

1 dosem

None

1

PRP-D

ProHIBIT ®

Aventis Pasteur

15-59

1 dosem

None

1

 

 

1.         Minimimally acceptable interval between doses is one month.

 

2.         At least 2 months after previous dose.

 

3.         After the primary infant Hib vaccine series is completed, any of the licensed Hib conjugate vaccines may be used as a booster dose.

 

4.         Children 15-59 months of age should receive only a single dose of Hib vaccine.

 

R          Registered name

 

(Source:  Amended at 26 Ill. Reg. 10689, effective July 1, 2002)